Intigus Pharmaceutical

Pharmaceutical solutions for neurological, psychiatric, and pain management in India.
Request Access
Report Incorrect Data
Annual revenue $78,108 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Intigus Pharmaceutical

Intigus Pharmaceutical is a company. Intigus Pharmaceutical offers products and services including CNS Medicines and Pain Management Drugs.

Operational Areas
Healthcare → Healthcare Products & Supplies → Unlock Sub-Sector → Unlock Segment
Healthcare → Healthcare Products & Supplies → Unlock Sub-Sector → Unlock Segment
Key Metrics
  • Annual Revenue
    $78.11 K (USD)
    0
    as on Mar 31, 2020
  • Net Profit
    $2.71 K (USD)
    0
    as on Mar 31, 2020
  • EBITDA
    -$300.96 (USD)
    0
    as on Mar 31, 2020
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Intigus Pharmaceutical

Intigus Pharmaceutical offers a comprehensive portfolio of products and services, including CNS Medicines and Pain Management Drugs.

Product name locked
Category locked
Primary

Medicines for neurological and psychiatric conditions are developed and supplied to address various disorders.

Product name locked
Category locked
Locked

Treatments for pain conditions are offered as part of the product range.

Funding Insights of Intigus Pharmaceutical

Premium access

Detailed funding history for Intigus Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Intigus Pharmaceutical

Investments
Premium access

Investment portfolio details for Intigus Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Intigus Pharmaceutical

Premium access

Detailed financials for Intigus Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Intigus Pharmaceutical Comparisons

Intigus Pharmaceutical Primary company
Description
Pharmaceutical solutions for neurological, psychiatric, and ...
Location
-
Founded Year
-
Annual Revenue
$78.11 K (USD)
Net Profit
$2.71 K (USD)
EBITDA
-$300.96 (USD)
Employees
Not available
Premium access

Peer comparison for Intigus Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Intigus Pharmaceutical

Premium access

Detailed competitors of Intigus Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Intigus Pharmaceutical

Premium access

Complete news archive for Intigus Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Intigus Pharmaceutical

Annual revenue of Intigus Pharmaceutical is $78.11K as on Mar 31, 2020.

Intigus Pharmaceutical is identified as a leader in the CNS segment across India, where high-quality and affordable medicines for neurological and psychiatric conditions have been provided for over five years. Specialized divisions such as Mindax and Brainax are utilized to target disorders like epilepsy, depression, and Parkinsons disease. Expansion into regions like Uttar Pradesh is pursued to enhance accessibility, while a focus on innovation, quality, and ethical practices is maintained to improve patient outcomes and societal impact.

Intigus Pharmaceutical offers CNS Medicines and Pain Management Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available